Racura secures green light for RC220 HARNESS-1 lung cancer trial

Racura Oncology’s lead drug candidate RC220 has cleared an important regulatory hurdle after receiving governance approval from Monash Health to start a phase I clinical trial in patients with ...
Knowridge Science Report

Severe COVID and flu may raise lung cancer risk years later

Respiratory illnesses such as COVID-19 and influenza are usually thought of as short-term infections that cause fever, cough, ...
Lawrence Journal-World

Ion robotic bronchoscopy transforms lung cancer detection

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
IEEE

Explainable AI-Driven Tree-Selection Stacking Random Forest with Hybrid Feature Synthesis for Lung Cancer Survival Time Prediction

Abstract: Accurately predicting lung cancer patient survival duration is crucial for medical research and informed clinical decision-making. This study presents a comprehensive regression framework ...